Functional Visual Symptoms: When Blurred Vision, Photophobia and Visual Snow Become FND
Blurred vision, double vision, light sensitivity, tunnel vision, visual snow, persistent visual images and even complete blindness. According to NeuroSymptoms, these can all fall within the spectrum of Functional Neurological Disorder (FND). The website, maintained by neurologist Jon Stone, provides a remarkably brief explanation of these presentations, describing several clinical findings associated with functional visual symptoms while offering little evidence of their diagnostic specificity.
The problem is not that functional visual loss has never been described or that clinical inconsistencies are irrelevant. It is the distance between identifying an unusual visual presentation and establishing what caused it. A symptom can occur in someone diagnosed with FND without being specific to FND, and a clinical finding can raise suspicion without reliably distinguishing functional visual loss from neurological or ophthalmological disease. That distinction becomes particularly important when the symptoms being discussed include potentially serious visual impairment.
From Blurred Vision to Blindness
NeuroSymptoms describes intermittent visual blurring and double vision as sometimes resulting from convergence spasm, where the eyes turn inward excessively. Convergence spasm is a recognised clinical phenomenon, but identifying abnormal convergence does not independently establish its cause. The same reasoning applies to photophobia, which the website associates with functional weakness, sensory symptoms and chronic fatigue syndrome. Light sensitivity also occurs in migraine, ocular surface disease, inflammation and other recognised conditions. Its presence alongside weakness does not demonstrate that either symptom has a functional origin.
The website also discusses severe visual loss, including blindness, suggesting that functional blindness can be diagnosed when pupillary responses, reactions to moving stimuli and the relevant visual brain structures are intact. This explanation requires considerably more qualification. Normal pupillary light reflexes do not establish intact conscious vision, as demonstrated by neurological conditions such as cortical blindness. Evidence that someone retains more visual function than initially apparent can be clinically important, but the examination must establish what that evidence actually demonstrates. Preserved reflexes, normal structural investigations and a functional diagnosis are not interchangeable conclusions.
Among the visual-field findings highlighted by NeuroSymptoms are tubular fields and spiral fields. These patterns have historically been associated with nonorganic or functional visual loss. However, a 2022 review in Survey of Ophthalmology acknowledges that spiralling and crossing of visual-field isopters can also result from fatigue and poor reproducibility. It explicitly cautions that no single test is diagnostic. The same review warns that unreliable visual-field results do not, by themselves, establish a functional disorder, because patients with recognised neurological or ophthalmological disease can also produce variable or unreliable results.
This is an important limitation. A pattern may be suggestive in a particular clinical context without being exclusive to a diagnosis. If fatigue, testing variability or an underlying disease can produce overlapping findings, clinicians need to establish how accurately the examination distinguishes the competing explanations rather than simply describing the pattern as functional.
Visual Snow: Another Condition Under the Functional Umbrella?
NeuroSymptoms also includes visual snow and visual persistence phenomena, suggesting that they may arise when the brain's normal filtering of visual information goes wrong. The page acknowledges possible neurological and ophthalmological explanations, including migraine, but nevertheless presents these disturbances as potentially functional. What it does not establish is how a clinician should distinguish a functional visual disturbance from a recognised visual snow syndrome or another neurological cause in an individual patient.
Visual snow syndrome is not merely an unexplained visual complaint waiting to be assigned to FND. It has a developing neurological research literature and proposed clinical diagnostic criteria involving persistent visual static and associated phenomena such as palinopsia, photophobia and impaired night vision. The overlap with the symptoms listed by NeuroSymptoms is obvious. What remains necessary is evidence that any proposed functional classification can be reliably differentiated from these other presentations. An explanation involving altered sensory filtering may sound plausible, but plausibility is not proof of a particular diagnosis.
What Jon Stone's Own 2026 Review Reveals
Perhaps the most revealing evidence comes from a systematic review and meta-analysis published on 26 June 2026, co-authored by Jon Stone. The researchers examined 44 studies involving 2,284 participants with functional visual loss, investigating epidemiology, prognosis and treatment. Their findings expose important limitations in the evidence base underlying this diagnostic category.
Most included studies were case series or case-control studies, with only eight conducted prospectively. Of the 44 studies, just seven enrolled at least 100 participants. The review also found that many studies failed to distinguish between patients experiencing symptomatic visual loss and those displaying functional visual signs that were asymptomatic or disproportionate to their reported difficulties. That distinction matters enormously when interpreting research findings: an unusual visual-field result discovered during testing is not necessarily equivalent to a patient experiencing disabling visual loss.
The review also identified limited treatment evidence. Only two treatment studies included more than ten participants, and neither had a control group. Prognostic findings were heterogeneous, while good-quality information about psychiatric comorbidity and adverse childhood experiences was unavailable. These findings do not establish that functional visual loss is an invalid diagnosis. They do, however, expose how much remains uncertain about the populations being studied, the natural history of their symptoms and the effectiveness of proposed interventions.
There is an obvious tension between the relatively confident patient-facing description on NeuroSymptoms and the substantial research limitations acknowledged in a review co-authored by the same neurologist. The website itself concedes that research on treatment for functional visual loss is limited. The 2026 review demonstrates just how limited that evidence remains. Importantly, the review was not designed to establish the diagnostic specificity of every sign described on NeuroSymptoms, so its findings cannot be treated as direct proof that those signs are inaccurate. They do, however, undermine any impression that functional visual loss is a thoroughly characterised condition with a well-established treatment evidence base.
The Diagnostic Problem Cannot Be Explained Away
The 2022 ophthalmology review provides another uncomfortable observation: patients initially diagnosed with functional visual disorders have subsequently been found to have conditions including macular degeneration, optic neuropathy, glaucoma, cone dystrophy, Stargardt disease and Leber hereditary optic neuropathy. The review cites a previous study reporting a misdiagnosis rate of approximately 2โ3%, while also documenting the possibility of functional visual presentations coexisting with recognised ophthalmological or neurological disease. That figure should not be generalised to every clinical setting, but the documented diagnostic errors are relevant, particularly because some affected patients had initially demonstrated inconsistent testing responses.
There is also a difference between demonstrating preserved visual ability and establishing the mechanism responsible for an apparent discrepancy. Clinical techniques may reveal that a patient's visual performance differs between testing conditions, but that finding must be interpreted alongside the full examination, relevant investigations and the known limitations of the tests. The observation itself does not reveal a specific underlying neurological mechanism. Nor does an absence of abnormalities on conventional imaging prove that every relevant disease process has been excluded.
NeuroSymptoms recommends gradual exposure to increasing light for patients with photophobia, warning that prolonged use of dark glasses may increase sensitivity. Yet photophobia is not a single disease with a single mechanism, and management depends on its cause. Advice that may be reasonable in a carefully assessed patient cannot automatically be applied to someone whose light sensitivity arises from migraine, ocular inflammation or another condition requiring different management. The same caution applies to treatment claims for functional visual loss, especially given the limited controlled evidence identified in the 2026 review.
The fundamental question is straightforward: what evidence establishes that a particular patient's blurred vision, visual-field abnormality, photophobia or visual snow is functional rather than a manifestation of another condition? It is not enough to demonstrate that such symptoms have previously been reported in people diagnosed with FND. That establishes an association within a diagnostic population, not the specificity or accuracy of the diagnosis itself.
Functional visual presentations deserve serious investigation, but so do the alternative explanations. When a patient-facing resource can place everything from intermittent blurring to blindness under the functional umbrella, the responsibility to demonstrate diagnostic discrimination becomes greater, not smaller. The research literature itself acknowledges important limitations. Those limitations should be reflected in the confidence of the clinical claims being made.
References
- NeuroSymptoms โ FND Symptoms. See the Visual Symptoms section.
- Ramsay N, Tessmann H, McKee J, Ercoli T, Stone J. (2026). Functional visual loss: a systematic review and meta-analysis of epidemiology, prognosis and treatment.
- Functional Vision Disorders in Adults: A Paradigm and Nomenclature Shift for Ophthalmology. Survey of Ophthalmology (2022).
- Yeo JM, Carson A, Stone J. (2019). Seeing again: treatment of functional visual loss. Practical Neurology, 19, 168โ172.
- Visual Snow Initiative โ Visual Snow Syndrome Information and Research.
Here's anotber useful ref!
New Study of Antidepressants and Vision Problems - RxISK https://share.google/eg2cFTtOEOGXWZhsJ